A phase I/II trial of preoperative chemoradiotherapy with gemcitabine in patients with pancreatic cancer and impaired renal function - A phase I/II trial of preoperative chemoradiotherapy with gemcitabine in patients with pancreatic cancer and impaired renal function

Clinical Study Group of Osaka University0 个研究点目标入组 8 人开始时间: 2015年3月30日最近更新: 2023年10月17日

试验速览

Refer to paper

•(1) Unresectable pancreatic cancer (2) Dialysis patients (3)Presence or past history of interstitial pneumonia or pulmonary fibrosis or possible (4) Active infections (excluding viral hepatitis) (5) Severe cardiac disorder, renal disorder, liver disorder, ulcer with bleeding, intestinal tract paralysis, uncontrollable diabetes mellitus (6) Presence of pleural effusion or ascites requiring drainage (7) Presence of metastasis in central nervous system (8) Active double cancer except carcinoma in situ or intramucosal cancer (synchronous double cancer or asynchronous double cancer with disease-free duration to be within 3 years) (9) Pregnant females or nursing mothers who can not stop lactation. Patients or partners, who don't attempt to doing contraception during the study period. (10) Severe mental disorder (11) Severe drug hypersensitivity (12) As determined by the principal investigator or the sub-investigator the subject is not adequate to participate in the trial.

发起方

Clinical Study Group of Osaka University